Godavari Biorefineries Limited Share Price & Analysis
₹280.15▲ +6.24%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹280.15
+6.24%
Open
₹—
High
₹282
Low
₹262.25
Close
₹280.15
52W High
₹354
52W Low
₹227
Volume
233K
Lot Size
1
Sector
Fast Moving Consumer Goods
Market Cap
₹1K Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
39
Sector P/E
40
P/B
1.82
EPS
₹4.41
ROE
4.28%
ROCE
6.55%
D/E Ratio
0.67
Div Yield
0%
Book Value
₹154
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| HINDUNILVR Hindustan Unilever Limited | ₹2,157 | ₹5.0L Cr | 33.1 | 10.42 | 31 | 28.4 | 0.04 |
| ITC ITC Limited | ₹281 | ₹3.5L Cr | 16.8 | 4.85 | 29.3 | 38.9 | 0.01 |
| NESTLEIND Nestle India Limited | ₹1,500 | ₹2.8L Cr | 80.9 | 56.18 | 74.2 | 85.3 | 0.09 |
| VBL Varun Beverages Limited | ₹462 | ₹1.6L Cr | 49.2 | 7.97 | 16.2 | 19.7 | 0.13 |
| BRITANNIA Britannia Industries Limited | ₹5,492 | ₹1.3L Cr | 51.5 | 25.91 | 53.6 | 56 | 0.59 |
| GODREJCP Godrej Consumer Products Limited | ₹1,071 | ₹1.1L Cr | 55.3 | 8.64 | 16.1 | 18.8 | 0.34 |
| MARICO Marico Limited | ₹862 | ₹1.1L Cr | 62.5 | 26.6 | 42.8 | 47 | 0.14 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
GODAVARIB · as of Mar 2026
Promoters63.31%
FII0.98%▲0.12
DII10.39%▼0.77
Public25.31%▲0.64
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% | 63.31% |
| FII | 1.14% | 0.96% | 0.63% | 0.60% | 0.86% | 0.98% |
| DII | 14.88% | 14.17% | 13.98% | 11.98% | 11.16% | 10.39% |
| Public | 20.67% | 21.56% | 22.09% | 24.11% | 24.67% | 25.31% |
Corporate Events
To consider and approve the financial results for the quarter and year ended on March 31, 2026
Results21 May 2026
Latest News
All news →Godavari Biorefineries wins cancer treatment patent in Japan
*Godavari Biorefineries wins cancer treatment patent in Japan*. The Japanese Patent Office granted a patent for '5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER'. This strengthens GBRL’s global IP portfolio and validates its R&D focus in oncology. Clinical and commercial success could drive future revenue streams. 📊 *STOCKS:* GBRL | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Patent
NSE Filing16 Jun
Godavari Biorefineries publishes re-lodgement notice for physical shares
*Godavari Biorefineries publishes re-lodgement notice for physical shares* — The company has issued a newspaper publication for the special window to re-lodge transfer requests of physical shares. This is a procedural step for shareholders holding physical certificates. No financial impact is expected. 📊 *STOCKS:* GODAVARISUG | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #PhysicalShares
NSE Filing19 Jun
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹460 Cr ▲6.7% | ₹431 Cr ▼19.1% | ₹533 Cr ▼8.1% | ₹580 Cr ▲29.8% | ₹447 Cr ▲39.3% | ₹321 Cr ▼38.6% | ₹523 Cr ▼15.0% | ₹615.19 Cr |
| Op. Profit | ₹43 Cr ▲637.5% | ₹-8 Cr ▼233.3% | ₹6 Cr ▼94.6% | ₹112 Cr ▲211.1% | ₹36 Cr ▲209.1% | ₹-33 Cr ▼175.0% | ₹-12 Cr ▼110.5% | ₹113.83 Cr |
| OPM | 9.0% ▲550.0% | -2.0% ▼300.0% | 1.0% ▼94.7% | 19.0% ▲137.5% | 8.0% ▲180.0% | -10.0% ▼400.0% | -2.0% ▼110.8% | 18.5% |
| Net Profit | ₹8 Cr ▲119.0% | ₹-42 Cr ▼162.5% | ₹-16 Cr ▼122.2% | ₹72 Cr ▲1100.0% | ₹6 Cr ▲108.0% | ₹-75 Cr ▼188.5% | ₹-26 Cr ▼139.9% | ₹65.17 Cr |
| EPS (₹) | 1.61 ▲119.8% | -8.13 ▼159.7% | -3.13 ▼122.3% | 14.06 ▲1144.2% | 1.13 ▲106.3% | -17.88 ▼187.0% | -6.23 ▼140.1% | 15.54 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹2.0K Cr ▲6.3% | ₹1.9K Cr ▲10.8% | ₹1.7K Cr ▼16.3% | ₹2.0K Cr ▲18.4% | ₹1.7K Cr ▲10.7% | ₹1.5K Cr ▲5.4% | ₹1.5K Cr |
| Expenses | ₹1.9K Cr ▲5.4% | ₹1.8K Cr ▲13.7% | ₹1.6K Cr ▼16.8% | ₹1.9K Cr ▲19.1% | ₹1.6K Cr ▲13.5% | ₹1.4K Cr ▲1.8% | ₹1.4K Cr |
| Op. Profit | ₹127 Cr ▲22.1% | ₹104 Cr ▼22.4% | ₹134 Cr ▼8.8% | ₹147 Cr ▲9.7% | ₹134 Cr ▼15.2% | ₹158 Cr ▲53.4% | ₹103 Cr |
| OPM | 6.0% ▲0.0% | 6.0% ▼25.0% | 8.0% ▲14.3% | 7.0% ▼12.5% | 8.0% ▼20.0% | 10.0% ▲42.9% | 7.0% |
| Other Income | ₹-19 Cr ▼218.8% | ₹16 Cr ▲14.3% | ₹14 Cr ▲100.0% | ₹7 Cr ▲16.7% | ₹6 Cr ▼25.0% | ₹8 Cr ▼42.9% | ₹14 Cr |
| Interest | ₹49 Cr ▼31.9% | ₹72 Cr ▼5.3% | ₹76 Cr ▲4.1% | ₹73 Cr ▲21.7% | ₹60 Cr ▼16.7% | ₹72 Cr ▲4.3% | ₹69 Cr |
| Depreciation | ₹54 Cr ▲8.0% | ₹50 Cr ▼16.7% | ₹60 Cr ▲20.0% | ₹50 Cr ▲4.2% | ₹48 Cr ▲2.1% | ₹47 Cr ▲4.4% | ₹45 Cr |
| PBT | ₹5 Cr ▲350.0% | ₹-2 Cr ▼116.7% | ₹12 Cr ▼62.5% | ₹32 Cr ▲0.0% | ₹32 Cr ▼30.4% | ₹46 Cr ▲1433.3% | ₹3 Cr |
| Tax % | 23.0% ▼98.4% | 1421.0% ▲142000.0% | 1.0% ▼97.4% | 38.0% ▼5.0% | 40.0% ▼2.4% | 41.0% ▲270.8% | -24.0% |
| Net Profit | ₹4 Cr ▲117.4% | ₹-23 Cr ▼291.7% | ₹12 Cr ▼40.0% | ₹20 Cr ▲5.3% | ₹19 Cr ▼29.6% | ₹27 Cr ▲575.0% | ₹4 Cr |
| EPS (₹) | 0.69 ▲115.1% | -4.57 ▼256.0% | 2.93 ▼37.4% | 4.68 ▲2.9% | 4.55 ▼29.7% | 6.47 ▲567.0% | 0.97 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹51 Cr ▲0.0% | ₹51 Cr ▲0.0% | ₹51 Cr ▲21.4% | ₹42 Cr ▲0.0% | ₹42 Cr ▲0.0% | ₹42 Cr ▲0.0% | ₹42 Cr ▲0.0% | ₹42 Cr |
| Reserves | ₹737 Cr ▲9.3% | ₹674 Cr ▼7.8% | ₹731 Cr ▲59.3% | ₹459 Cr ▲2.5% | ₹448 Cr ▲3.9% | ₹431 Cr ▲4.6% | ₹412 Cr ▲7.0% | ₹385 Cr |
| Borrowings | ₹531 Cr ▲7.7% | ₹493 Cr ▲0.6% | ₹490 Cr ▼25.2% | ₹655 Cr ▼11.0% | ₹736 Cr ▲15.7% | ₹636 Cr ▲11.8% | ₹569 Cr ▼3.4% | ₹589 Cr |
| Other Liabilities | ₹733 Cr ▲198.0% | ₹246 Cr ▼64.0% | ₹683 Cr ▼18.3% | ₹836 Cr ▲61.4% | ₹518 Cr ▼17.1% | ₹625 Cr ▲49.2% | ₹419 Cr ▲0.2% | ₹418 Cr |
| Total Liabilities | ₹2.1K Cr ▲40.3% | ₹1.5K Cr ▼25.2% | ₹2.0K Cr ▼1.9% | ₹2.0K Cr ▲14.2% | ₹1.7K Cr ▲0.6% | ₹1.7K Cr ▲20.2% | ₹1.4K Cr ▲0.6% | ₹1.4K Cr |
| Assets | ||||||||
| Fixed Assets | ₹885 Cr ▲2.9% | ₹860 Cr ▼0.2% | ₹862 Cr ▲1.4% | ₹850 Cr ▼1.8% | ₹866 Cr ▲29.8% | ₹667 Cr ▼5.8% | ₹708 Cr ▼3.7% | ₹735 Cr |
| CWIP | ₹129 Cr ▲59.3% | ₹81 Cr ▲118.9% | ₹37 Cr ▲27.6% | ₹29 Cr ▲70.6% | ₹17 Cr ▼66.0% | ₹50 Cr ▲455.6% | ₹9 Cr ▼47.1% | ₹17 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.0K Cr ▲98.9% | ₹522 Cr ▼50.5% | ₹1.1K Cr ▼5.2% | ₹1.1K Cr ▲29.4% | ₹860 Cr ▼15.4% | ₹1.0K Cr ▲40.1% | ₹725 Cr ▲6.1% | ₹683 Cr |
| Total Assets | ₹2.1K Cr ▲40.3% | ₹1.5K Cr ▼25.2% | ₹2.0K Cr ▼1.9% | ₹2.0K Cr ▲14.2% | ₹1.7K Cr ▲0.6% | ₹1.7K Cr ▲20.2% | ₹1.4K Cr ▲0.6% | ₹1.4K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹171 Cr ▲2750.0% | ₹6 Cr ▼96.8% | ₹185 Cr ▼6.1% | ₹197 Cr ▲337.8% | ₹45 Cr ▼65.4% | ₹130 Cr ▼48.0% | ₹250 Cr |
| Investing CF | ₹-163 Cr ▼136.2% | ₹-69 Cr ▼56.8% | ₹-44 Cr ▲79.4% | ₹-214 Cr ▼345.8% | ₹-48 Cr ▼585.7% | ₹-7 Cr ▲69.6% | ₹-23 Cr |
| Financing CF | ₹-6 Cr ▼109.4% | ₹64 Cr ▲142.4% | ₹-151 Cr ▼639.3% | ₹28 Cr ▲366.7% | ₹6 Cr ▲105.0% | ₹-121 Cr ▲46.5% | ₹-226 Cr |
| Net Cash Flow | ₹3 Cr ▲200.0% | ₹1 Cr ▲110.0% | ₹-10 Cr ▼190.9% | ₹11 Cr ▲266.7% | ₹3 Cr ▲50.0% | ₹2 Cr ▲100.0% | ₹1 Cr |
| Free Cash Flow | ₹6 Cr ▲109.2% | ₹-65 Cr ▼150.0% | ₹130 Cr ▲750.0% | ₹-20 Cr ▼300.0% | ₹-5 Cr ▼104.2% | ₹119 Cr ▼46.6% | ₹223 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 21d ▼22.2% | 27d ▼34.1% | 41d ▲10.8% | 37d ▲0.0% | 37d ▼7.5% | 40d ▲29.0% | 31d |
| Inventory Days | 198d ▲1.5% | 195d ▼22.0% | 250d ▲82.5% | 137d ▼31.5% | 200d ▲37.0% | 146d ▲12.3% | 130d |
| Days Payable | 146d ▲4.3% | 140d ▼28.2% | 195d ▲85.7% | 105d ▼40.3% | 176d ▲33.3% | 132d ▲7.3% | 123d |
| Cash Conv. Cycle | 74d ▼9.8% | 82d ▼13.7% | 95d ▲39.7% | 68d ▲11.5% | 61d ▲10.9% | 55d ▲41.0% | 39d |
| Working Capital Days | 16d ▼23.8% | 21d ▲250.0% | -14d ▼800.0% | 2d ▼33.3% | 3d ▲200.0% | 1d ▲101.5% | -68d |
| ROCE | 7.0% ▲16.7% | 6.0% ▼14.3% | 7.0% ▼22.2% | 9.0% ▲0.0% | 9.0% ▼25.0% | 12.0% | — |
Source: Screener.in · Lower days = better efficiency
About Godavari Biorefineries Limited
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
Fast Moving Consumer Goods · Diversified FMCG
Related Analysis
Frequently Asked Questions
What is Godavari Biorefineries Limited share price today?▾
Godavari Biorefineries Limited (GODAVARIB) is currently trading at ₹280.15 on NSE, up 6.24% as of the last market session. Prices update daily after market close on MarketNetra.
Is Godavari Biorefineries Limited available in F&O (Futures & Options)?▾
Yes, Godavari Biorefineries Limited (GODAVARIB) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Godavari Biorefineries Limited 52-week high and low?▾
Godavari Biorefineries Limited's 52-week high is ₹354 and the 52-week low is ₹227. The current price of ₹280.15 is 20.9% below the 52W high.
What is Godavari Biorefineries Limited P/E ratio?▾
Godavari Biorefineries Limited's current P/E ratio is 39. This indicates the market is paying ₹39 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Godavari Biorefineries Limited options?▾
Godavari Biorefineries Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade GODAVARIB options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.